(Q43168054)

15 November 2017

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients (English)

1 reference

15 November 2017

0 references

A Verrijken

1

1 reference

15 November 2017

S Francque

2

1 reference

15 November 2017

I Mertens

3

1 reference

15 November 2017

M Talloen

4

1 reference

15 November 2017

F Peiffer

5

1 reference

15 November 2017

L Van Gaal

6

1 reference

15 November 2017

language of work or name

English

0 references

publication date

9 February 2010

1 reference

International Journal of Obesity

15 November 2017

1 reference

15 November 2017

34

1 reference

15 November 2017

5

1 reference

15 November 2017

899-907

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2010.4

15 November 2017

0 references

cites work

Nonalcoholic steatohepatitis: pathologic features and differential diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Epidemiology of nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Body mass index, diabetes, and C-reactive protein among U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Mechanisms linking obesity with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Regulation of adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Minireview: Adiposity, Inflammation, and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

Elevated C-reactive protein levels in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Management of dyslipidemia in children and adolescents with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Assessment of fat-free mass using bioelectrical impedance measurements of the human body.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Changes in fat-free mass during weight loss measured by bioelectrical impedance and by densitometry

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.4

7 January 2021

Identifiers

DOI

10.1038/IJO.2010.4

1 reference

Dimensions Publication ID

15 November 2017

0 references

1 reference